Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > former Trump advisor charged with illegal foreing lobbying
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(548)
•••
Comment by Rumpl3StiltSkinon Jul 22, 2021 6:03pm
135 Views
Post# 33591710

RE:RE:RE:RE:RE:RE:RE:RE:former Trump advisor charged with illegal foreing lobbying

RE:RE:RE:RE:RE:RE:RE:RE:former Trump advisor charged with illegal foreing lobbying
socksnblonds642 wrote: Isn't no news good news right now? Other people have done the math on here and we are a year and a half to two years before we get complete results. Even if news came out that they got BTD I think it would only move it to $.80 or so. I Don't think I'd sell too many, if any at that! Not sure what they could say in a report right now that would tip the scales.


Yep, That is what my math is like. Only if Dr. Kelbasa and the PHCA team held a joint news conferense, praising the new 'Canadian Covid cure', would we see the spike $$ we want.

To sleep better I'd want to know that they have treated at least ~40 patients for the NMIBC study 2, whenever we get there, hopefully soon. Then the FDA would have some reasonable CR numbers to look at.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities